Clinical Trials Logo

Photodamaged Skin clinical trials

View clinical trials related to Photodamaged Skin.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06170346 Active, not recruiting - Photodamaged Skin Clinical Trials

Effect of Topical Agents With Various Antioxidant Containts on Photodamage Skin Induced

Start date: November 1, 2022
Phase: Phase 2
Study type: Interventional

Ultraviolet (UV) irradiation of the skin leads to acute inflammatory reactions such as erythema, sunburn, and chronic reactions, including premature skin aging and skin tumors. UV irradiation is a potent generator of oxidative stress in the skin. Exposure of mammalian skin to UV increases the cellular levels of reactive oxygen species, which damages lipids, proteins, and nucleic acids in both epidermal and dermal cells and contributes to the sunburn reaction as well as photocarcinogenesis and photoaging. In this study, the effects of a topical antioxidant on attenuating the harmful effects of UV irradiation on normal healthy volunteers were studied using biomarkers of skin damage. This study confirms the protective role of a unique mixture of antioxidants on human skin from the harmful effects of UV irradiation. We propose that antioxidant mixture will complement and synergize with sunscreens in providing photoprotection for human skin.

NCT ID: NCT05963204 Active, not recruiting - Photodamaged Skin Clinical Trials

A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator With a Skincare Regimen

Start date: July 7, 2023
Phase: N/A
Study type: Interventional

To assess skin structural change in midface after treatment with a biostimulator using Line-Field Optical Coherence Tomography

NCT ID: NCT05456334 Active, not recruiting - Actinic Keratoses Clinical Trials

New Treatments for Actinic Keratoses of the Scalp

Start date: March 24, 2016
Phase: N/A
Study type: Interventional

This blinded controlled 2-year study on 120 patients with 2 or more actinic keratoses, compare the efficacy and tolerability of pulsed dye-laser- mediated photodynamic therapy compared to conventional photodynamic therapy and fractional-laser assisted daylight photodynamic therapy compared to daylight photodynamic therapy.

NCT ID: NCT04096742 Active, not recruiting - Photoaging Clinical Trials

Altreno for Chest Rejuvenation

Start date: August 6, 2019
Phase: Phase 4
Study type: Interventional

This is a single-center, prospective, double-blind, randomized, vehicle-controlled study to evaluate the efficacy, safety and patient satisfaction of tretinoin 0.05% lotion (Altreno) for chest rejuvenation.